TextMed All Sources
 
TextMed   :   TextMap   :   Textblg   :   TextBiz   :   Make homepage!   :   Link to us   :   Help?
 
Relations for heparin
heparin Main Page
Entity 1 Relationship Entity 2 Article Frequency Score
heparin inducedthrombocytopeniaComplications of heparin therapy.   66  75.1962
warfarin followheparinTreatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation.   34  69.0711
thrombocytopenia complicationheparinHeparin-associated thrombocytopenia.   7  39.8642
heparin released-fromenzymeLipoprotein lipase: evidence for high- and low-affinity enzyme sites.   6  34.3523
danaparoid replacedheparinThrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients.   1  33.8033
heparin compete-withheparanEfficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate.   1  33.5576
heparin followingstreptokinaseAustralian multicentre trial of streptokinase in acute myocardial infarction.   5  33.5174
pentasacchariderepresentingheparinFurther characterization of the antithrombin-binding sequence in heparin.   2  33.4228
thrombolysis superiorheparinThrombolytic therapy of non-cardiac disorders.   2  33.2243
heparinase removedheparinDetection of HIV-1 RNA in heparinized plasma of HIV-1 seropositive individuals.   1  33.1792
disaccharide derived-fromheparinDiagnostic enzymology of alpha-L-iduronidase with special reference to a sulphated disaccharide derived from heparin.   2  32.2863
heparin treatmentthromboembolism[Contraceptive agents and thrombosis]   1  32.2804
heparin derived-fromporcineThrombocytopenia found uncommonly during heparin therapy.   2  31.8824
heparin releaselipasePulmonary macrophage: a major source of lipoprotein lipase in the lung.   2  31.4069
heparin inhibitorfactor xiaSERPIN regulation of factor XIa. The novel observation that protease nexin 1 in the presence of heparin is a more potent inhibitor of factor XIa than C1 inhibitor.   1  31.0503
sulfate effectiveheparinMechanism of potentiation of antithrombin III [AT-III] inhibition by sulfated xylans.   1  30.9242
ticlopidine superiorheparinCurrent oral antiplatelet agents to prevent atherothrombosis.   1  30.8182
bradyarrhythmia associated-withheparinHeparin-induced life-threatening hyperkalemia.   1  30.7012
heparin associatedthrombocythemia[Acute thrombosis of the right renal vein. Two cases with coagulopathies]   1  30.7012
heparin not-associated-with3-sulfateAdverse effects of alkali and acid on the anticoagulant potency of heparin, evaluated with methyl 2-deoxy-2-sulfamino-alpha-D-glucopyranoside 3-sulfate as a model compound.   1  30.7012
heparin associated-withhypotension[Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin]   1  30.7012
heparin associated-withhyperkalemiaHeparin-induced hyperkalemia.   1  30.7012
heparin associated-withischemiaRole of heparin after intravenous thrombolytic therapy for acute myocardial infarction.   1  30.7012
heparin associated-withrespiratory distress syndromeFeasibility of extracorporeal on-line large-scale plasma adsorptions on protein A-sepharose columns in cancer patients.   1  30.7012
heparin associated-withosteoporoticEpidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology.   1  30.7012
dipyridamole followheparinConsumption coagulopathy and microangiopathic hemolytic anemia with an axillo-femoral graft.   2  30.5174
acid followheparinLDL hemoperfusion--a new procedure for LDL apheresis: first clinical application of an LDL adsorber compatible with human whole blood.   2  30.5174
phenprocoumon followheparinLow-dose aspirin versus anticoagulants for prevention of coronary graft occlusion.   2  30.5174
heparin releaselipoprotein lipaseEndothelin-1, but not endothelin-3, suppresses lipoprotein lipase gene expression in brown adipocytes differentiated in culture.   2  30.3523
lipoprotein lipase responsibleheparinLipoprotein lipase. Molecular model based on the pancreatic lipase x-ray structure: consequences for heparin binding and catalysis.   1  30.1808
thrombopenia related-toheparin[Thrombopenia caused by heparin. Review of the literature apropos of a personal case]   2  30.0586
heparin producefatty acidsThe parallel effects of a very low molecular weight heparin (CY222) on anti Xa activity and thyroid hormone levels in blood.   2  29.9769
tetrasaccharide derived-fromheparinEvidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.   3  29.8947
priapism occurring-duringheparinPriapism: an unusual complication of heparin therapy for sudden deafness.   2  29.7744
heparin causeabnormalitiesHypothermia and bleeding during abdominal aortic aneurysm repair.   1  29.7013
heparin not-causeneutropeniaTransient neutropenia induced by transfusion of blood exposed to nylon fiber filters.   1  29.7013
heparin studied-inpigsThe hemodynamic effects of intra-aortic versus intravenous administration of protamine for reversal of heparin in pigs.   2  29.6074
heparin developedphlebitisUse of heparin to lower the incidence of phlebitis induced by anti-neoplastic agents used in ovarian cancer.   1  29.5212
plasmapheresis followingheparin[Radioimmunodiagnosis in the correction of plasmapheresis methodology in thyrotoxicosis]   1  29.5174
ethyl alcohol followheparinHeparinized human umbilical vein grafts. Delayed heparin desorption after alcohol treatment.   1  29.5174
pulse methylprednisolone followheparinRenal amyloidosis associated with crescentic glomerulonephritis.   1  29.5174
4-hour followheparinIndium-111-labeled platelets: effects of heparin on uptake by venous thrombi and relationship to the activated partial thromboplastin time.   1  29.5174
heparin followingdeep vein thrombosis[Should adjuvant treatments (antiplatelet agents, anticoagulants, normovolaemic haemodilution and vasodilators) be used in cervicofacial and maxillofacial free flaps reconstructive surgery?]   1  29.5174
myocardial infarction includeheparinRelation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial.   1  29.4205
infection includeheparinAdvances in parenteral nutrition.   1  29.4205
atheroma includeheparinThe pathogenesis of atheroma and the rationale for its treatment.   1  29.4205
polypeptide hadheparinStructural comparisons of fibronectins isolated from early and late passage cells.   1  29.4103
heparin hadhepatic artery thrombosisHepatic artery thrombosis after orthotopic liver transplantation.   1  29.4103
heparin releasedphospholipaseA heparin-sensitive phospholipase A2 and prostaglandin endoperoxide synthase-2 are functionally linked in the delayed phase of prostaglandin D2 generation in mouse bone marrow-derived mast cells.   1  29.3523
heparin releasehistaminaseResponse of plasma histaminase activity to heparin in normal subjects and in patients with small cell carcinoma of the lung.   1  29.3523
 
Copyright (c) 2007 The Research Foundation of State University of New York
Computer Science Department at Stony Brook University